绝经前特发性骨质疏松女性低骨形成率与更高体脂及更高IGF-1相关
该辅助研究基于34例绝经前特发性骨质疏松(IOP)女性,分析基线血清IGF-1与骨形成率、体脂及特立帕肽反应的关系。结果发现,低骨形成率与高体脂、较差的特立帕肽反应相关,且这些均与更高IGF-1相关,呈现矛盾关系。提示IGF-1对骨和脂肪的异常调节可能参与绝经前IOP的发病机制。
要点
- 绝经前IOP女性中,低骨形成率与高体脂及较差特立帕肽反应相关。
- IGF-1 Z评分与所有骨表面骨形成率呈负相关(r=-0.39至-0.46,p<0.05)。
- IGF-1与中心脂肪(p=0.05)和瘦素(p=0.03)正相关,与24个月髋部BMD变化率负相关(r=-0.46,p=0.01)。
核心结论
- 绝经前IOP女性中IGF-1与骨形成率、体脂及特立帕肽反应的关系呈矛盾性,提示骨与脂肪的异常调节可能参与骨质疏松机制。
研究设计与样本
- 本研究为一项为期24个月的特立帕肽治疗IOP临床试验的辅助研究,基线评估与试验结局(BMD、骨重塑)相关。
- 研究对象为34例绝经前IOP女性,骨重塑状态由基线骨活检的松质骨BFR/BS定义。
主要发现
- 低骨形成率与更高体脂和更差的特立帕肽反应相关。
- IGF-1 Z评分与所有骨表面骨形成率呈负相关(r=-0.39至-0.46;p<0.05)。
- IGF-1与中心脂肪(p=0.05)和瘦素(p=0.03)直接相关。
- IGF-1与24个月髋部BMD百分比变化呈负相关(r=-0.46;p=0.01)。
关键数值与推荐
- 骨重塑状态以基线骨活检的松质骨BFR/BS定义。
- IGF-1 Z评分与骨形成率负相关(r=-0.39至-0.46;p<0.05)。
- IGF-1与中心脂肪相关(p=0.05),与瘦素相关(p=0.03)。
- IGF-1与24个月髋部BMD百分比变化负相关(r=-0.46;p=0.01)。
临床怎么用
- 在绝经前IOP女性中,评估血清IGF-1可能有助于识别低骨形成率及对特立帕肽反应较差的患者。
- 对于绝经前IOP女性,高IGF-1可能提示骨形成低下和体脂增加,需关注其骨健康。
局限性
- 本研究为辅助研究,样本量较小(n=34)。
- 骨重塑状态仅基于基线骨活检的松质骨BFR/BS定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We examined serum IGF-1 in premenopausal IOP, finding relationships that were opposite to those expected: higher IGF-1 was associated with lower bone formation and higher body fat, and lower BMD response to teriparatide. These paradoxical relationships between serum IGF-1, bone, and fat may contribute to the mechanism of idiopathic osteoporosis in premenopausal women. INTRODUCTION: Premenopausal women with idiopathic osteoporosis (IOP) have marked deficits in bone microarchitecture but variable bone remodeling. We previously reported that those with low tissue-level bone formation rate (BFR) are less responsive to teriparatide and have higher serum IGF-1, a hormone anabolic for osteoblasts and other tissues. The IGF-1 data were unexpected because IGF-1 is low in other forms of low turnover osteoporosis-leading us to hypothesize that IGF-1 relationships are paradoxical in IOP. This study aimed to determine whether IOP women with low BFR have higher IGF-1 and paradoxical IGF-1 relationships in skeletal and non-skeletal tissues, and whether IGF-1 and the related measures predict teriparatide response. METHODS: This research is an ancillary study to a 24 month clinical trial of teriparatide for IOP. Baseline assessments were related to trial outcomes: BMD, bone remodeling. SUBJECTS: Premenopausal women with IOP(n = 34); bone remodeling status was defined by baseline cancellous BFR/BS on bone biopsy. MEASURES: Serum IGF-1 parameters, compartmental adiposity (DXA, CT, MRI), serum hormones, and cardiovascular-risk-markers related to fat distribution. RESULTS: As seen in other populations, lower BFR was associated with higher body fat and poorer teriparatide response. However, in contrast to observations in other populations, low BFR, higher body fat, and poorer teriparatide response were all related to higher IGF-1: IGF-1 Z-score was inversely related to BFR at all bone surfaces (r = - 0.39 to - 0.46; p < 0.05), directly related to central fat (p = 0.05) and leptin (p = 0.03). IGF-1 inversely related to 24 month hip BMD %change (r = - 0.46; p = 0.01). CONCLUSIONS: Paradoxical IGF-1 relationships suggest that abnormal or atypical regulation of bone and fat may contribute to osteoporosis mechanisms in premenopausal IOP.
引用
- Goetz TG, Nair N, Shiau S, et al. In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1. Osteoporos Int. 2021. PMID: 34665288. doi:10.1007/s00198-021-06196-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。